CRH has primary listings on the Irish and London Stock Exchanges
and its ADRs are listed on the New York Stock Exchange (NYSE).
The Directors are committed to maintaining the highest standards
of corporate governance and this statement describes how CRH
applies the main and supporting principles of section 1 of the
Combined Code on Corporate Governance (June 2006) published by the
Financial Reporting Council in the UK.
Board of Directors
Corporate social
responsibility
Code of business
conduct
Communications with
shareholders
Internal control
Going concern
Compliance
Attendance at Board
and Board Committee meetings
Remuneration
consultants
NYSE Statement of
Differences
Board of Directors
Role
The Board is responsible for the leadership and control of the
Company. There is a formal schedule of matters reserved to the
Board for consideration and decision. This includes Board
appointments, approval of strategic plans for the Group, approval
of financial statements, the annual budget, major acquisitions and
significant capital expenditure, and review of the Group’s
system of internal controls.
The Board has delegated responsibility for the management of the
Group, through the Chief Executive, to executive management. The
roles of Chairman and Chief Executive are not combined and there is
a clear division of responsibilities between them, which is set out
in writing and has been approved by the Board. The Chief Executive
is accountable to the Board for all authority delegated to
executive management.
The Board has also delegated some of its responsibilities to
Committees of the Board. Individual Directors may seek independent
professional advice, at the expense of the Company, in the
furtherance of their duties as a Director.
The Group has a policy in place which indemnifies the Directors
in respect of legal action taken against them.
Membership
It is the practice of CRH that a majority of the Board comprises
non-executive Directors and that the Chairman be non-executive. At
present, there are three executive and nine non-executive
Directors. Biographical details
are available to view on this website. The Board considers that,
between them, the Directors bring the range of skills, knowledge
and experience, including international experience, necessary to
lead the Company.
Directors are appointed for specified terms and subject to the
Memorandum and Articles of Association of the Company.
All of the Directors bring independent judgement to bear on
issues of strategy, performance, resources, key appointments and
standards. The Board has determined that each of the non-executive
Directors is independent. In reaching that conclusion, the Board
considered the principles relating to independence contained in the
Combined Code and the guidance provided by a number of shareholder
voting agencies. Those principles and guidance address a number of
factors that might appear to affect the independence of Directors,
including former service as an executive, extended service on the
Board and cross-directorships. However, they also make clear that a
Director may be considered independent notwithstanding the presence
of one or more of these factors. This reflects the Board’s
view that independence is determined by a Director’s
character, objectivity and integrity. Where relevant, the Board
took account of these factors and in each case was satisfied that
the Director’s independence was not compromised.
Chairman
Mr. Kieran McGowan succeeded Mr. Pat Molloy as Chairman on Mr.
Molloy’s retirement following the Annual General Meeting on
9th May 2007. On his appointment as Chairman, Mr. McGowan met the
independence criteria set out in the Combined Code. The Chairman is
responsible for the efficient and effective working of the Board.
He ensures that Board agendas cover the key strategic issues
confronting the Group; that the Board reviews and approves
management’s plans for the Group; and that Directors receive
accurate, timely, clear and relevant information. While Mr. McGowan
holds a number of other
directorships, the Board
considers that these do not interfere with the discharge of his
duties to CRH.
Senior Independent Director
The Board has appointed Mr. David Kennedy as the Senior Independent
Director. Mr. Kennedy is available to shareholders who have
concerns that cannot be addressed through the Chairman, Chief
Executive or Finance Director. On Mr. Kennedy’s retirement
from the Board on 7th May 2008, Mr. Nicky Hartery will take on the
role of Senior Independent Director.
Company Secretary
The appointment and removal of the Company Secretary is a matter
for the Board. All Directors have access to the advice and services
of the Company Secretary, who is responsible to the Board for
ensuring that Board procedures are complied with.
Terms of appointment
The standard terms of the letter of appointment of non-executive
Directors is available, on request, from the Company Secretary.
Induction and development
New Directors are provided with extensive briefing materials on the
Group and its operations. Directors meet with key executives and,
in the course of twice-yearly visits by the Board to Group
locations, see the businesses at first hand and meet with local
management teams.
Remuneration
Details of remuneration paid to the Directors (executive and
non-executive) are set out in the Report on
Directors' remuneration.
Share ownership and dealing
View the details of the
shares held by Directors.
CRH has a policy on dealings in securities that applies to
Directors and senior management. Under the policy, Directors are
required to obtain clearance from the Chairman and Chief Executive
before dealing in CRH shares. Directors and senior management are
prohibited from dealing in CRH shares during designated prohibited
periods and at any time at which the individual is in possession of
price-sensitive information. The policy adopts the terms of the
Model Code, as set out in the Listing Rules published by the UK
Listing Authority and the Irish Stock Exchange.
Performance appraisal
The Senior Independent Director conducts an annual review of
corporate governance, the operation and performance of the Board
and its Committees and the performance of the Chairman. This is
achieved through discussion with each Director.
A review of individual Directors’ performance is conducted
by the Chairman and each Director is provided with feedback
gathered from other members of the Board. Performance is assessed
against a number of measures, including the ability of the Director
to contribute to the development of strategy, to understand the
major risks affecting the Group, to contribute to the cohesion of
the Board, to commit the time required to fulfil the role, and to
listen to and respect the views of other Directors and the
management team.
Directors’ retirement and re-election
The Board has determined that when a non-executive Director has
served on the Board for more than nine years, that Director will be
subject to annual re-election. Of the remaining Directors, at least
one-third retire at each Annual General Meeting and Directors must
submit themselves to shareholders for re-election every three
years. Re-appointment is not automatic. Directors who are seeking
re-election are subject to a performance appraisal, which is
overseen by the Nomination Committee.
Directors appointed by the Board must submit themselves to
shareholders for election at the Annual General Meeting following
their appointment.
Board succession planning
The Board plans for its own succession with the assistance of the
Nomination Committee. In so doing, the Board
considers the skill, knowledge and experience necessary to allow it
to meet the strategic vision for the Group.
The Board engages the services of independent consultants to
undertake a search for suitable candidates to serve as
non-executive Directors.
Meetings
There were eight full meetings of the Board during 2007. Details of
Directors'
attendance at those meetings are available to view on this
website. The Chairman sets the agenda for each meeting, in
consultation with the Chief Executive and Company Secretary. Two
visits are made each year by the Board to Group operations; one in
Europe and one in North America. Each visit lasts between three and
five days and incorporates a scheduled Board meeting. In 2007,
these visits were to Poland and to Texas, Oklahoma and Arkansas in
the United States. Additional meetings, to consider specific
matters, are held when and if required. Board papers are circulated
to Directors in advance of meetings.
The non-executive Directors met twice during 2007 without
executives being present.
Committees
The Board has established five permanent Committees to assist in
the execution of its responsibilities. These are the Acquisitions
Committee, the Audit Committee, the Finance Committee, the
Nomination Committee and the Remuneration Committee. Ad hoc
committees are formed from time to time to deal with specific
matters.
Each of the permanent Committees has
terms of reference,
under which authority is delegated to them by the Board. The terms
of reference are available on the Group's website,
www.crh.com. The Chairman of each
Committee reports to the Board on its deliberations and minutes of
all Committee meetings are circulated to all Directors.
The current membership of each
Committee is available to view
on this website. Attendance at
meetings held in
2007 are available to view on this website.
Chairmen of the Committees attend the Annual General Meeting and
are available to answer questions from shareholders.
During the year each of the relevant Committees reviewed its
performance and terms of reference.
The role of the
Acquisitions Committee is to approve
acquisitions and capital expenditure projects within limits agreed
by the Board.
The Audit Committee consists of four non-executive
Directors, considered by the Board to be independent. The Board has
determined that Mr. Jan Maarten de Jong, Mr. Terry Neill and Mr.
Dan O’Connor are the Committee’s financial experts. It
will be seen from the Directors'
biographical details, that the members of the Committee bring
to it a wide range of experience and expertise.
The Committee met twelve times during the year under review. The
Finance Director and the Head of Internal Audit normally attend
meetings of the Committee, while the Chief Executive and other
executive Directors attend when necessary. The external auditors
attend as required and have direct access to the Committee Chairman
at all times. During the year, the Committee met with the Head of
Internal Audit and with the external auditors in the absence of
management.
The main role and responsibilities are set out in written
terms of reference
and include:
- monitoring the integrity of the Group's
financial statements and reviewing significant financial reporting
issues and judgements contained therein;
- reviewing the effectiveness of the
Group’s internal financial controls;
- monitoring and reviewing the effectiveness of
the Group’s internal auditors;
- making recommendations to the Board on the
appointment and removal of the external auditors and approving
their remuneration and terms of engagement; and
- monitoring and reviewing the external
auditors’ independence, objectivity and effectiveness, taking
into account professional and regulatory
requirements.
These responsibilities are discharged as follows:
- the Committee reviews the trading statements
issued by the Company in January and July;
- at a meeting in February, the Committee
reviews the Company’s preliminary results announcement/Annual
Report and accounts. The Committee receives reports at that meeting
from the external auditors identifying any accounting or
judgemental issues requiring its attention;
- the Committee also meets with the external
auditors to review the Annual Report on Form 20-F, which is filed
annually with the United States Securities and Exchange
Commission;
- in August, the Committee reviews the interim
report;
- the external auditors present their audit
plans in advance to the Committee;
- the Committee approves the annual internal
audit plan;
- regular reports are received from the Head of
Internal Audit on reviews carried out; and
- the Head of Internal Audit also reports to
the Committee on other issues including, in the year under review,
progress on the implementation of Section 404 of the Sarbanes-Oxley
Act 2002 and the arrangements in place to enable employees to raise
concerns, in confidence, in relation to possible wrongdoing in
financial reporting or other matters.
As noted above, one of the duties of the Audit Committee is to
make recommendations to the Board in relation to the appointment of
the external auditors. A number of factors are taken into account
by the Committee in assessing whether to recommend the auditors for
re-appointment. These include:
- the quality of reports provided to the Audit
Committee and the Board, and the quality of advice
given;
- the level of understanding demonstrated of
the Group's business and industry; and
- the objectivity of the auditors’ views
on the financial controls around the Group and their ability to
co-ordinate a global audit, working to tight
deadlines.
The Committee has put in place safeguards to ensure that the
independence of the audit is not compromised. Such safeguards
include:
- seeking confirmation that the auditors are,
in their professional judgement, independent from the
Group;
- obtaining from the external auditors an
account of all relationships between the auditors and the
Group;
- monitoring the number of former employees of
the external auditors currently employed in senior positions in the
Group and assessing whether those appointments impair, or appear to
impair, the auditors’ judgement or independence;
- considering whether, taken as a whole, the
various relationships between the Group and the external auditors
impair, or appear to impair, the auditors’ judgement or
independence; and
- reviewing the economic importance of the
Group to the external auditors and assessing whether that
importance impairs, or appears to impair, the external
auditors’ judgement or independence.
The Group has a policy governing the conduct of non-audit work
by the auditors. Under that policy, the auditors are prohibited
from performing services where the auditors:
- may be required to audit their own
work;
- participate in activities that would normally
be undertaken by management;
- are remunerated through a 'success fee'
structure, where success is dependent on the audit; or
- act in an advocacy role for the
Group.
Other than the above, the Group does not impose an automatic ban
on the Group auditors undertaking non-audit work. The auditors are
permitted to provide non-audit services that are not, or are not
perceived to be, in conflict with auditor independence, providing
they have the skill, competence and integrity to carry out the work
and are considered by the Committee to be the most appropriate to
undertake such work in the best interests of the Group. The
engagement of the external auditors to provide any non-audit
services must be pre-approved by the Audit Committee or entered
into pursuant to pre-approval policies and procedures established
by the Committee.
The Group audit engagement partner rotates every five years.
View details of the amounts paid to the external auditors during
the year for audit and other services in the
notes on financial statements of the Annual
Report (note 4).
The Finance Committee advises the Board on the
financial requirements of the Group and on appropriate funding
arrangements.
The Nomination Committee assists the Board in
ensuring that the composition of the Board and its Committees is
appropriate to the needs of the Group by:
- assessing the skills, knowledge, experience
and diversity required on the Board and the extent to which each
are represented;
- establishing processes for the identification
of suitable candidates for appointment to the Board;
and
- overseeing succession planning for the Board
and senior management.
To facilitate the search for suitable candidates to serve as
non-executive Directors, the Committee uses the services of
independent consultants.
During 2007, the Committee identified, and recommended to the
Board, a suitable candidate for appointment as a non-executive
Director. The Committee also reviewed succession planning at senior
management level in the four operating Divisions.
The Remuneration Committee, which consists solely
of non-executive Directors considered by the Board to be
independent:
- determines the Group's policy on executive
remuneration;
- determines the remuneration of the executive
Directors;
- monitors the level and structure of
remuneration for senior management; and
- reviews and approves the design of all share
incentive plans.
The Committee receives advice from leading independent firms of
compensation and benefit consultants when necessary and the Chief
Executive is fully consulted about remuneration proposals. The
Committee oversees the preparation of the
Report on Directors' Remuneration.
In 2007, the Committee determined the salaries of the executive
Directors and awards under the performance-related incentive plans;
set the remuneration of the Chairman; and reviewed the remuneration
of senior management. It also approved the award of share options
to the executive Directors and key management and the conditional
allocation of shares under the Performance Share Plan.
A Succession Committee has been appointed to make
recommendations to the Board in relation to the appointment of a
new Chief Executive to succeed Mr. Liam O’Mahony, whose
retirement at the end of 2008 has been announced. The members of
this committee are Mr. Kieran McGowan, Mr. Nicky Hartery, Mr. Jan
Maarten de Jong, Mr. David Kennedy and Mr. Terry Neill.
Corporate Social
Responsibility
Corporate Social Responsibility is embedded in all CRH
operations and activities. Excellence in environmental, health,
safety and social performance is a daily key priority of line
management. Group policies and implementation systems are
summarised in the
Annual Report 2007 and are described in detail
in the
CSR Report on the Group’s website,
www.crh.com. During 2007, CRH was
again recognised by several key rating agencies as being among the
leaders in its sector in respect of sustainability performance.
Code of Business Conduct
The CRH Code of Business Conduct is applicable to
all Group employees and is supplemented by local codes throughout
the Group’s operations. The Code is available on the
Group’s website,
www.crh.com. Regional hotline
facilities are in place, to enable employees to report suspected
breaches of the Code. The Board recently approved a new Code of
Business Conduct, which will be rolled out to the operating
companies during the course of 2008.
Communications with
Shareholders
Communications with shareholders are given high priority and
there is regular dialogue with institutional shareholders, as well
as presentations at the time of the release of the annual and
interim results. Conference calls are held following the issuance
of trading statements and major announcements by the Group, which
afford Directors the opportunity to hear investors’ reactions
to the announcements and their views on other issues.
Trading statements are issued in January and July. Major
acquisitions are notified to the Stock Exchanges in accordance with
the requirements of the Listing Rules. In addition, development
updates, giving details of other acquisitions completed and major
capital expenditure projects, are issued in January and July each
year.
During 2007, the Board received reports from management on the
issues raised by investors in the course of presentations following
the annual and interim results.
This website, www.crh.com,
provides the full text of the Annual
and Interim Reports, the Annual
Report on Form 20-F, which is filed
annually with the United States Securities and Exchange Commission,
trading statements and copies
of presentations to
analysts and investors. News
releases are made available in the News & Media section of
this website immediately after release to the Stock Exchanges.
The Company's Annual General
Meeting affords individual shareholders the opportunity to
question the Chairman and the Board. Notice of the Annual General
Meeting is sent to shareholders at least 20 working days before the
meeting. At the meeting, after each resolution has been dealt with,
details are given of the level of proxy votes lodged, the balance
for and against that resolution and the number of abstentions. This
information is made available on the Company’s website
following the meeting.
In addition, the Company responds throughout the year to
numerous letters from shareholders on a wide range of issues.
Internal Control
The Directors have overall responsibility for the Group’s
system of internal control and for reviewing its effectiveness.
Such a system is designed to manage rather than eliminate the risk
of failure to achieve business objectives and can provide only
reasonable and not absolute assurance against material misstatement
or loss.
The Directors confirm that the Group’s ongoing process for
identifying, evaluating and managing its significant risks is in
accordance with the updated Turnbull guidance (Internal
Control: Revised Guidance for Directors on the Combined Code)
published in October 2005. The process has been in place throughout
the accounting period and up to the date of approval of the Annual
Report and financial statements and is regularly reviewed by the
Board.
Group management has responsibility for major strategic
development and financing decisions. Responsibility for operational
issues is devolved, subject to limits of authority, to product
group and operating company management. Management at all levels is
responsible for internal control over the respective business
functions that have been delegated. This embedding of the system of
internal control throughout the Group’s operations ensures
that the organisation is capable of responding quickly to evolving
business risks, and that significant internal control issues,
should they arise, are reported promptly to appropriate levels of
management.
The Board receives, on a regular basis, reports on the key risks
to the business and the steps being taken to manage such risks. It
considers whether the significant risks faced by the Group are
being identified, evaluated and appropriately managed, having
regard to the balance of risk, cost and opportunity. In addition,
the Audit Committee meets with internal auditors on a regular basis
and satisfies itself as to the adequacy of the Group’s
internal control system. The Audit Committee also meets with and
receives reports from the external auditors. The Chairman of the
Audit Committee reports to the Board on all significant issues
considered by the Committee and the minutes of its meetings are
circulated to all Directors.
The Directors confirm that they have conducted an annual review
of the effectiveness of the system of internal control up to and
including the date of approval of the financial statements. This
had regard to the material risks that could affect the Group's
business (as outlined in the
Directors' Report), the methods of managing
those risks, the controls that are in place to contain them and the
procedures to monitor them.
Going Concern
After making enquiries, the Directors have a reasonable
expectation that the Company, and the Group as a whole, have
adequate resources to continue in operational existence for the
foreseeable future. For this reason, they continue to adopt the
going concern basis in preparing the financial statements.
Compliance
In the period under review, CRH complied with the provisions set
out in section 1 of the Combined Code. The Company also complied
with the rules issued by the United States Securities and Exchange
Commission to implement the Sarbanes-Oxley Act 2002, in so far as
they apply to the Group.
Remuneration consultants
The Remuneration Committee has appointed Mercer Human Resource
Consulting as remuneration consultants. Mercer also provide
actuarial advice to the Group and are actuaries and investment
advisers to a number of the Group’s pension schemes.
NYSE Statement of Differences
CRH and the New York Stock Exchange (NYSE) corporate
governance rules
CRH American Depositary Shares (ADSs) are listed on the NYSE.
Each CRH ADS represents one CRH Ordinary Share and one tied Income
Share.
Although non-US companies like CRH are exempt from most of the
corporate governance rules of the NYSE, pursuant to Rule 303A.11 of
the NYSE Listing Manual we are required to disclose any significant
ways in which our corporate governance practices differ from those
followed by domestic U.S. companies listed on the NYSE. In common
with companies listed on the Irish Stock Exchange and the London
Stock Exchange, CRH’s corporate governance practices reflect,
inter alia, compliance with (a) domestic company law; (b) the
Listing Rules of the Irish Stock Exchange and the UK Listing
Authority; and (c) the Combined Code on Corporate Governance
(Combined Code), which is appended to the listing rules of the
Irish and London Stock Exchanges.
Independence. The NYSE rules require that a
majority of the Board of Directors must be comprised of independent
directors, and the rules provide detailed tests that U.S. companies
must use for determining independence. While the CRH Board does not
specifically apply the NYSE’s tests, the Board has carried
out an assessment in accordance with the Combined Code requirements
as to whether there are relationships or circumstances which are
likely to affect, or could appear to affect, the directors’
judgement, and the Board has determined that each of the eight
non-executive directors are independent having regard to the
Combined Code. As of 30 March 2006, CRH’s Board consisted of
five executive directors and eight non-executive directors,
including the Chairman.
Committees. The NYSE rules require U.S.
companies to have a Nominating / Corporate Governance Committee, a
Compensation Committee and an Audit Committee, each of which must
meet certain requirements. CRH’s Nomination, Remuneration and
Audit Committees have terms of reference and composition that
comply with the Combined Code. CRH’s Nomination Committee
membership consists of the Chairman of CRH, the Chief Executive and
non-executive directors (whom the Board has determined to be
independent in the manner described above). The Remuneration
Committee is composed entirely of non-executive directors (whom the
Board has determined to be independent in the manner described
above). CRH’s Audit Committee is composed entirely of
non-executive directors (whom the Board has determined to be
independent in the manner described above and who meet the
requirements of U.S. Securities Exchange Act Rule 10A-3). CRH
considers that the terms of reference of these committees are
generally responsive to the relevant NYSE rules, but may not
address all aspects of these rules.
Code of Business Conduct and Ethics. The NYSE
rules require companies to adopt and disclose a code of business
conduct and ethics for directors, officers and employees. CRH has
adopted a Code of Business Conduct, which applies to all directors,
officers and employees and considers that its Code of Business
Conduct is generally responsive to the relevant NYSE rules, but may
not address all aspects of these rules.
Shareholder Approval of Equity Compensation
Plans. The NYSE rules require that shareholders must be
given the opportunity to vote on all equity-compensation plans and
material revisions to those plans. CRH complies with Irish
requirements, which are similar to the NYSE rules. The CRH Board,
however, does not explicitly take into consideration the
NYSE’s detailed definition of what are considered
“material revisions”.
|